China Health Group Inc. (FRA:VNL1)

Germany · Delayed Price · Currency is EUR

0.0015

-0.0005 (-25.00%)

At close: Jun 26, 2026

-84.21% (1Y)

Market Cap	11.13M -39.6%
Revenue (ttm)	3.48M +8.0%
Net Income	-1.82M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0010
Previous Close	0.0020
Day's Range	0.0010 - 0.0015
52-Week Range	0.0010 - 0.0300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About China Health Group

China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People’s Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in ... [Read more]

Industry Pharmaceutical Preparations

Founded 1998

Employees 32

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol VNL1

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY Financial Statements